Acceso abierto

Shared decision-making for gene therapy in haemophilia care

Simon Fletcher

Simon Fletcher

Haemnet LtdLondon, UK
Perfil de Orcid
Buscar este autor en
Sciendo|Google Scholar
Fletcher, Simon
, 
Kathryn Jenner

Kathryn Jenner

Haemnet LtdLondon, UK
Perfil de Orcid
Buscar este autor en
Sciendo|Google Scholar
Jenner, Kathryn
 y 
Kate Khair

Kate Khair

Haemnet LtdLondon, UK
Perfil de Orcid
Buscar este autor en
Sciendo|Google Scholar
Khair, Kate
  
09 ago 2023
Shared decision-making for gene therapy in haemophilia care's Cover Image
Acerca de este artículo
Artículo anterior
Artículo siguiente
Cite
Descargar portada
Categoría del artículo: Clinical Practice
Publicado en línea: 09 ago 2023
Páginas: 62 - 67
DOI: https://doi.org/10.2478/jhp-2023-0009
Palabras clave
© 2023 Simon Fletcher et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Education and support during the shared decision-making process is key to ensuring that people with haemophilia are able to make informed therapeutic choices as gene therapy becomes more widely available as a treatment option
Education and support during the shared decision-making process is key to ensuring that people with haemophilia are able to make informed therapeutic choices as gene therapy becomes more widely available as a treatment option

Figure 1.

The patient decision-making journey in the current treatment landscape (cf. Wang et al., 2022) [19]
The patient decision-making journey in the current treatment landscape (cf. Wang et al., 2022) [19]
Idioma:
Inglés
Calendario de la edición:
1 veces al año
Temas de la revista:
Medicina, Ciencias médicas básicas, Ciencias médicas básicas, otros, Medicina Clínica, Medicina Clínica, otros, Farmacia, Farmacología
RSS Feed de revista